Caisse de depot et placement du Quebec Takes Position in Privia Health Group, Inc. $PRVA

Posted by Stanley Muller on Aug 30th, 2026

Caisse de depot et placement du Quebec bought a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 326,424 shares of the company’s stock, valued at approximately $8,399,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Bayban acquired a new stake in Privia Health Group in the 4th quarter valued at $26,000. Hantz Financial Services Inc. raised its position in Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after purchasing an additional 926 shares during the period. Global Retirement Partners LLC lifted its stake in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after purchasing an additional 1,351 shares in the last quarter. Allworth Financial LP acquired a new position in shares of Privia Health Group during the second quarter worth about $48,000. Finally, Harbor Investment Advisory LLC purchased a new stake in shares of Privia Health Group in the second quarter worth about $69,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on PRVA shares. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Canaccord Genuity Group set a $32.00 price target on Privia Health Group in a report on Friday, August 7th. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Barclays dropped their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Finally, Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Read Our Latest Analysis on PRVA

Insider Buying and Selling

In related news, CFO David Mountcastle sold 24,734 shares of Privia Health Group stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total value of $680,185.00. Following the completion of the sale, the chief financial officer owned 186,728 shares in the company, valued at approximately $5,135,020. The trade was a 11.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 88,110 shares of the company’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $25.33, for a total transaction of $2,231,826.30. Following the completion of the sale, the director directly owned 76,651 shares in the company, valued at $1,941,569.83. This represents a 53.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 327,886 shares of company stock worth $8,628,256. 5.70% of the stock is currently owned by corporate insiders.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $20.79 on Friday. The business has a 50-day moving average of $24.33 and a 200-day moving average of $23.18. The company has a market capitalization of $2.66 billion, a PE ratio of 99.00, a P/E/G ratio of 1.64 and a beta of 0.85. Privia Health Group, Inc. has a 1-year low of $19.53 and a 1-year high of $28.82.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.12. The business had revenue of $632.63 million for the quarter, compared to analyst estimates of $597.33 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%.The company’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.24 earnings per share. On average, equities analysts expect that Privia Health Group, Inc. will post 0.27 earnings per share for the current fiscal year.

Privia Health Group Profile

(Free Report)

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.